Actinium Pharmaceuticals Statistics
Total Valuation
ATNM has a market cap or net worth of $207.54 million. The enterprise value is $132.97 million.
| Market Cap | 207.54M |
| Enterprise Value | 132.97M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ATNM has 29.40 million shares outstanding. The number of shares has increased by 10.20% in one year.
| Shares Outstanding | 29.40M |
| Shares Change (YoY) | +10.20% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 2.16% |
| Owned by Institutions (%) | 24.63% |
| Float | 28.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.84 |
| PS Ratio | 2,562.20 |
| Forward PS | n/a |
| PB Ratio | 5.70 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,641.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.21, with a Debt / Equity ratio of 0.06.
| Current Ratio | 9.21 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -102.60% and return on invested capital (ROIC) is -134.89%.
| Return on Equity (ROE) | -102.60% |
| Return on Assets (ROA) | -52.60% |
| Return on Capital (ROIC) | -134.89% |
| Revenue Per Employee | $1,653 |
| Profits Per Employee | -$996,286 |
| Employee Count | 49 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.81% in the last 52 weeks. The beta is 0.08, so ATNM's price volatility has been lower than the market average.
| Beta (1Y) | 0.08 |
| 52-Week Price Change | -24.81% |
| 50-Day Moving Average | 7.73 |
| 200-Day Moving Average | 6.24 |
| Relative Strength Index (RSI) | 40.94 |
| Average Volume (30 Days) | 364,396 |
Short Selling Information
The latest short interest is 2.19 million, so 7.44% of the outstanding shares have been sold short.
| Short Interest | 2.19M |
| Short Previous Month | 1.80M |
| Short % of Shares Out | 7.44% |
| Short % of Float | 7.64% |
| Short Ratio (days to cover) | 4.19 |
Income Statement
In the last 12 months, ATNM had revenue of $81,000 and -$48.82 million in losses. Loss per share was -$1.83.
| Revenue | 81,000 |
| Gross Profit | 81,000 |
| Operating Income | -51.92M |
| Pretax Income | -48.82M |
| Net Income | -48.82M |
| EBITDA | -48.03M |
| EBIT | -48.82M |
| Loss Per Share | -$1.83 |
Balance Sheet
The company has $76.68 million in cash and $2.11 million in debt, giving a net cash position of $74.56 million or $2.54 per share.
| Cash & Cash Equivalents | 76.68M |
| Total Debt | 2.11M |
| Net Cash | 74.56M |
| Net Cash Per Share | $2.54 |
| Equity / Book Value | 36.38M |
| Book Value Per Share | 1.24 |
| Working Capital | 69.77M |
Cash Flow
In the last 12 months, operating cash flow was -$47.34 million and capital expenditures -$153,000, giving a free cash flow of -$47.49 million.
| Operating Cash Flow | -47.34M |
| Capital Expenditures | -153,000 |
| Free Cash Flow | -47.49M |
| FCF Per Share | -$1.79 |
Margins
Gross margin is 100.00%, with operating and profit margins of -64,098.77% and -60,269.14%.
| Gross Margin | 100.00% |
| Operating Margin | -64,098.77% |
| Pretax Margin | -60,269.14% |
| Profit Margin | -60,269.14% |
| EBITDA Margin | -59,293.83% |
| EBIT Margin | -60,269.14% |
| FCF Margin | -58,627.16% |
Dividends & Yields
ATNM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.20% |
| Shareholder Yield | -10.20% |
| Earnings Yield | -23.52% |
| FCF Yield | -22.88% |
Analyst Forecast
The average price target for ATNM is $25.72, which is 264.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.72 |
| Price Target Difference | 264.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 462.08% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.
| Last Split Date | Aug 11, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
ATNM has an Altman Z-Score of -3.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.99 |
| Piotroski F-Score | 2 |